[DISCLOSURE] KD Pharm (011040) announced on Aug. 12 in its semi-annual report that its consolidated operating profit in the first half of this year decreased 14.6 percent on-year to 13.7 billion won (US$ 12.43 million).

Sales in the period went up 1.6 percent to 74.8 billion won and net profit decreased 4.4 percent to 9.9 billion won.